{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:19:35Z","timestamp":1791425975570,"version":"4.3.3"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.antiviral.2006.08.008","type":"journal-article","created":{"date-parts":[[2006,9,23]],"date-time":"2006-09-23T11:29:16Z","timestamp":1159010956000},"page":"140-146","source":"Crossref","is-referenced-by-count":49,"title":["Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model"],"prefix":"10.1016","volume":"73","author":[{"given":"Justin G.","family":"Julander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Morrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence M.","family":"Blatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"Shafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Sidwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2006.08.008_bib1","first-page":"989","article-title":"Adverse events associated with 17D-derived yellow fever vaccination\u2014United States, 2001\u20132002","volume":"51","author":"Anon.","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.antiviral.2006.08.008_bib2","first-page":"647","article-title":"Effect of human gamma interferon on yellow fever virus infection","volume":"38","author":"Arroyo","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2006.08.008_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jcv.2004.12.001","article-title":"Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium","volume":"33","author":"Bae","year":"2005","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2006.08.008_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-0934(03)00129-0","article-title":"Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay","volume":"110","author":"Bae","year":"2003","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2006.08.008_bib5","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1099\/0022-1317-71-10-2301","article-title":"Attenuation of wild-type yellow fever virus by passage in HeLa cells","volume":"71","author":"Barrett","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2006.08.008_bib6","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1016\/j.transproceed.2005.09.170","article-title":"Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival","volume":"37","author":"Bestard","year":"2005","journal-title":"Transplant Proc."},{"key":"10.1016\/j.antiviral.2006.08.008_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0166-3542(99)00063-7","article-title":"Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis","volume":"44","author":"Bolger","year":"1999","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.08.008_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0344-0338(11)81176-3","article-title":"Human fatal yellow fever. Immunohistochemical detection of viral antigens in the liver, kidney and heart","volume":"188","author":"De Brito","year":"1992","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.antiviral.2006.08.008_bib9","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1128\/AAC.49.6.2378-2386.2005","article-title":"Interferon alfacon-1 protects hamsters from lethal pichinde virus infection","volume":"49","author":"Gowen","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2006.08.008_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/viro.2002.1462","article-title":"Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates","volume":"298","author":"Guirakhoo","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2006.08.008_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/jir.1995.15.231","article-title":"Comparison of the in vitro host range of recombinant met-interferon-con 1, interferon-alpha 2b, and interferon-beta","volume":"15","author":"Hu","year":"1995","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2006.08.008_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/095632020301400304","article-title":"Viramidine, a prodrug of ribavirin, shows better liver-targeting properties and safety profiles than ribavirin in animals","volume":"14","author":"Lin","year":"2003","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2006.08.008_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0035-9203(03)00006-3","article-title":"Aedes aegypti in Brazil: genetically differentiated populations with high susceptibility to dengue and yellow fever viruses","volume":"98","author":"Lourenco-de-Oliveira","year":"2004","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2006.08.008_bib14","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1001\/jama.290.24.3222","article-title":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study","volume":"290","author":"Loutfy","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2006.08.008_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2006.08.008_bib16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/516111","article-title":"Imported yellow fever in a United States citizen","volume":"25","author":"McFarland","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.08.008_bib17","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20052388","article-title":"Protective immune responses against West Nile virus are primed by distinct complement activation pathways","volume":"203","author":"Melhop","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2006.08.008_bib18","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/JVI.76.4.1932-1943.2002","article-title":"Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines","volume":"76","author":"Monath","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2006.08.008_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0065-3527(03)60009-6","article-title":"Pathogenesis and pathophysiology of yellow fever","volume":"60","author":"Monath","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2006.08.008_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/095632020401500202","article-title":"Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models","volume":"15","author":"Morrey","year":"2004","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2006.08.008_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2004.02.005","article-title":"Modeling hamsters for evaluating West Nile virus therapies","volume":"63","author":"Morrey","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.08.008_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4269\/ajtmh.2004.71.306","article-title":"Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease","volume":"71","author":"Sbrana","year":"2004","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2006.08.008_bib23","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4269\/ajtmh.2006.74.1084","article-title":"Experimental yellow fever virus infection in the Golden hamster (Mesocictus auratus). III. Clinical laboratory values","volume":"74","author":"Sbrana","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2006.08.008_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2005.06.003","article-title":"In vitro and in vivo influenza virus-inhibitory effects of viramidine","volume":"68","author":"Sidwell","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2006.08.008_bib25","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10620-005-2564-2","article-title":"Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C","volume":"50","author":"Sjogren","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.antiviral.2006.08.008_bib26","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/320199","article-title":"Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies","volume":"183","author":"Tesh","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2006.08.008_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10408360490497474","article-title":"Yellow fever: the recurring plague","volume":"41","author":"Tomori","year":"2004","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.antiviral.2006.08.008_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2006.08.008_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0035-9203(03)90023-X","article-title":"Isolations of yellow fever virus from Haemagogus leucocelaenus in Rio Grande do Sul State, Brazil","volume":"97","author":"Vasconcelos","year":"2003","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2006.08.008_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.virol.2004.06.015","article-title":"Yellow fever 17D virus: pseudo-revertant suppression of defective virus penetration and spread by mutations in domains II and III of the E protein","volume":"15","author":"Vlaycheva","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2006.08.008_bib31","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1086\/320200","article-title":"Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology","volume":"183","author":"Xiao","year":"2001","journal-title":"J. Infect. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206002804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354206002804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T09:01:07Z","timestamp":1555837267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354206002804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0166354206002804"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2006.08.008","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}